Ternary raises $4.4 million to fight inflammation with synthetic drugs

London-based Ternary Therapeutics is betting that AI-engineered “molecular glues” can tame chronic inflammation, opening new doors to longevity medicine. located in London Triple therapy Raised $4.4 million (€4.1 million) in a seed round led by Paris-based VC daphni, alongside Pace…












